Reverse transcriptase - PDFSEARCH.IO - Document Search Engine

Reverse transcriptase
Results: 600

#	Item
461	Analysis for the Resistance Collaborative Group Add to Reading List Source URL: www.fda.gov Language: English - Date: 1999-10-29 04:20:04 Protease inhibitors Organofluorides Amides Cyclopropanes Antiretroviral drug Viral load HIV Reverse-transcriptase inhibitor Efavirenz Chemistry Organic chemistry HIV/AIDS
462	OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIDEX safely and effectively. See full prescribing information for VIDEX. • Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-01-29 12:00:31 Health Didanosine Pharmacology Tenofovir Stavudine Norfloxacin Antiretroviral drug Adverse effect Reverse-transcriptase inhibitor Purines Bristol-Myers Squibb Medicine
463	January 5, [removed]Vol[removed]Nos. 51 &[removed]Serious Adverse Events Attributed to Nevirapine Regimens for Postexposure Prophylaxis After HIV Exposures — Worldwide, 1997–2000 Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2001-08-06 10:02:32 HIV/AIDS Medical terms Ketones Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Post-exposure prophylaxis Nevirapine Antiretroviral drug AIDS Medicine Health Chemistry
464	Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2013-10-30 10:15:46 Tuberculosis Organofluorides Non-nucleoside reverse transcriptase inhibitors Cyclopropanes Rifamycin antibiotics Efavirenz Nevirapine Tuberculosis treatment Antiretroviral drug Chemistry Organic chemistry Medicine
465	Please note: An erratum has been published for this issue. To view the erratum, please click here. Morbidity and Mortality Weekly Report Recommendations and Reports November 22, [removed]Vol[removed]No. RR-18 Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2002-11-27 11:42:19 Medicine Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Protease inhibitors Azides Zidovudine Antiretroviral drug HIV AIDS Chemistry Organic chemistry HIV/AIDS
466	HIV Resistance Collaborative Group Data Analysis Plan for Resistance Add to Reading List Source URL: www.fda.gov Language: English - Date: 1999-10-29 04:20:00 Purines Organofluorides Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Reverse-transcriptase inhibitor Antiretroviral drug Lamivudine Nevirapine Efavirenz Chemistry Organic chemistry Cyclopropanes
467	1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT safely and effectively. See full prescribing information for EDURANT. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-05-20 11:23:31 Carbamates Protease inhibitors Pyrimidines Nitriles Rilpivirine Efavirenz Darunavir Etravirine Reverse-transcriptase inhibitor Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors
468	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. • Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-06-10 15:35:43 Fixed dose combination Pharmacology Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Organofluorides Tenofovir Emtricitabine/tenofovir/efavirenz Emtricitabine Efavirenz Gilead Sciences Chemistry Organic chemistry
469	• New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess creatinine clearance (CrCl) before initiating treatment with COMPLERA. Monitor CrCl and serum phosphorus in pati Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-08-11 15:26:08 Fixed dose combination Medicine Bristol-Myers Squibb Non-nucleoside reverse transcriptase inhibitors Organofluorides Tenofovir Emtricitabine/tenofovir/efavirenz Rilpivirine Fixed-dose combination Gilead Sciences Chemistry Organic chemistry
470	[ Unable To Translate Box ] MILLER REPORTING COMPANY, INC. 507 C Street, N.E. Washington, D.C[removed] Add to Reading List Source URL: www.fda.gov Language: English - Date: 1999-11-29 07:58:34 Health Assay Virco Antiretroviral drug HIV AIDS Viral load Reverse-transcriptase inhibitor Nelfinavir HIV/AIDS Chemistry Medicine

UPDATE